000282460 001__ 282460
000282460 005__ 20240229155041.0
000282460 0247_ $$2doi$$a10.1016/S2352-3026(23)00242-9
000282460 0247_ $$2pmid$$apmid:37652598
000282460 0247_ $$2ISSN$$a2352-3026
000282460 0247_ $$2ISSN$$a2451-9960
000282460 037__ $$aDKFZ-2023-01775
000282460 041__ $$aEnglish
000282460 082__ $$a610
000282460 1001_ $$aDöhner, Hartmut$$b0
000282460 245__ $$aAll systems are not GO: ongoing challenges in interpreting gemtuzumab ozogamicin clinical trial results - Authors' reply.
000282460 260__ $$aLondon [u.a.]$$bElsevier$$c2023
000282460 3367_ $$2DRIVER$$aarticle
000282460 3367_ $$2DataCite$$aOutput Types/Journal article
000282460 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1693827086_11016$$xLetter
000282460 3367_ $$2BibTeX$$aARTICLE
000282460 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000282460 3367_ $$00$$2EndNote$$aJournal Article
000282460 500__ $$aCorrespondence
000282460 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000282460 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000282460 7001_ $$0P:(DE-He78)e15dfa1260625c69d6690a197392a994$$aBenner, Axel$$b1$$udkfz
000282460 7001_ $$aGanser, Arnold$$b2
000282460 773__ $$0PERI:(DE-600)2802056-X$$a10.1016/S2352-3026(23)00242-9$$gVol. 10, no. 9, p. e707 -$$n9$$pe707$$tThe lancet <London> / Haematology$$v10$$x2352-3026$$y2023
000282460 909CO $$ooai:inrepo02.dkfz.de:282460$$pVDB
000282460 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e15dfa1260625c69d6690a197392a994$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000282460 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000282460 9141_ $$y2023
000282460 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2022-11-19
000282460 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2022-11-19
000282460 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bLANCET HAEMATOL : 2022$$d2023-08-26
000282460 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-08-26
000282460 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-08-26
000282460 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-08-26
000282460 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-08-26
000282460 915__ $$0StatID:(DE-HGF)9920$$2StatID$$aIF >= 20$$bLANCET HAEMATOL : 2022$$d2023-08-26
000282460 9201_ $$0I:(DE-He78)C060-20160331$$kC060$$lC060 Biostatistik$$x0
000282460 980__ $$ajournal
000282460 980__ $$aVDB
000282460 980__ $$aI:(DE-He78)C060-20160331
000282460 980__ $$aUNRESTRICTED